Yale-New Haven Medical Center Renal & Genitourinary Pathology Selective Pathology

Topics

• Bladder and Urothelial Cancer Treatments 42
• Thyroid Cancer Diagnosis and Treatment 33
• Renal cell carcinoma treatment 28
• Renal Diseases and Glomerulopathies 18
• Prostate Cancer Diagnosis and Treatment 15
• Pancreatic and Hepatic Oncology Research 13
• Cancer Immunotherapy and Biomarkers 12
• Neuroendocrine Tumor Research Advances 11
• Chronic Kidney Disease and Diabetes 10
• Cervical Cancer and HPV Research 9
• Genetic and Kidney Cyst Diseases 9
• Lymphoma Diagnosis and Treatment 8

Most cited

1. An integrated multi-omics analysis identifies prognostic molecular subtypes of non-muscle-invasive bladder cancer.

   Nature communications · 2021 · 296 citations · Joshua Warrick

2. New developments in existing WHO entities and evolving molecular concepts: The Genitourinary Pathology Society (GUPS) update on renal neoplasia.

   Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc · 2021 · 217 citations · Adebowale Adeniran

3. A comparison of sunitinib with cabozantinib, crizotinib, and savolitinib for treatment of advanced papillary renal cell carcinoma: a randomised, open-label, phase 2 trial.

   Lancet (London, England) · 2021 · 241 citations · Adebowale Adeniran

4. Novel, emerging and provisional renal entities: The Genitourinary Pathology Society (GUPS) update on renal neoplasia.

   Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc · 2021 · 186 citations · Adebowale Adeniran

5. Identification and validation of urinary CXCL9 as a biomarker for diagnosis of acute interstitial nephritis.

   The Journal of clinical investigation · 2023 · 64 citations · Gilbert Moeckel

6. An independent assessment of an artificial intelligence system for prostate cancer detection shows strong diagnostic accuracy.